ADAM-17 regulates endothelial cell morphology, proliferation, and in vitro angiogenesis

Biochemical and Biophysical Research Communications

Volumn 380, Issue 1, 2009, Pages 33-38

  Göoz, Pal ^a   Göoz, Monika ^b   Baldys, Aleksander ^b   Hoffman, Stanley ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

ADAM 17; Angiogenesis; HB EGF; HUVEC; Invasion; Lentivirus; MMP 2; Proliferation; siRNA; VEGF

Indexed keywords

GELATINASE A; LENTIVIRUS VECTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL CONTACT; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UMBILICAL VEIN;

ADAM PROTEINS; CELL PROLIFERATION; ENDOTHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; MATRIX METALLOPROTEINASE 2; NEOVASCULARIZATION, PHYSIOLOGIC; UMBILICAL CORD; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

LENTIVIRUS;

EID: 59649123850     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.01.013     Document Type: Article

References (20)

1. D'Amore P.A., and Ng Y.S. Won't you be my neighbor? Local induction of arteriogenesis. Cell 110 (2002) 289-292
2. Roy R., Zhang B., and Moses M.A. Making the cut: protease-mediated regulation of angiogenesis. Exp. Cell Res. 312 (2006) 608-622
3. Rundhaug J.E. Matrix metalloproteinases and angiogenesis. J. Cell Mol. Med. 9 (2005) 267-285
4. Moss M.L., Jin S.L., Milla M.E., Bickett D.M., Burkhart W., Carter H.L., Chen W.J., Clay W.C., Didsbury J.R., Hassler D., Hoffman C.R., Kost T.A., Lambert M.H., Leesnitzer M.A., McCauley P., McGeehan G., Mitchell J., Moyer M., Pahel G., Rocque W., Overton L.K., Schoenen F., Seaton T., Su J.L., Becherer J.D., et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385 (1997) 733-736
5. Huovila A.P., Turner A.J., Pelto-Huikko M., Karkkainen I., and Ortiz R.M. Shedding light on ADAM metalloproteinases. Trends Biochem. Sci. 30 (2005) 413-422
6. Zhao J., Chen H., Peschon J.J., Shi W., Zhang Y., Frank S.J., and Warburton D. Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis. Dev. Biol. 232 (2001) 204-218
7. Shi W., Chen H., Sun J., Buckley S., Zhao J., Anderson K.D., Williams R.G., and Warburton D. TACE is required for fetal murine cardiac development and modeling. Dev. Biol. 261 (2003) 371-380
8. Gooz M., Gooz P., Luttrell L.M., and Raymond J.R. 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells. J. Biol. Chem. 281 (2006) 21004-21012
9. Tremblay P.L., Hudon V., Berthod F., Germain L., and Auger F.A. Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am. J. Transplant. 5 (2005) 1002-1010
10. Garton K.J., Gough P.J., Philalay J., Wille P.T., Blobel C.P., Whitehead R.H., Dempsey P.J., and Raines E.W. Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J. Biol. Chem. 278 (2003) 37459-37464
11. Ongusaha P.P., Kwak J.C., Zwible A.J., Macip S., Higashiyama S., Taniguchi N., Fang L., and Lee S.W. HB-EGF is a potent inducer of tumor growth and angiogenesis. Cancer Res. 64 (2004) 5283-5290
12. Lal H., Guleria R.S., Foster D.M., Lu G., Watson L.E., Sanghi S., Smith M., and Dostal D.E. Integrins: novel therapeutic targets for cardiovascular diseases. Cardiovasc. Hematol. Agents Med. Chem. 5 (2007) 109-132
13. Bax D.V., Messent A.J., Tart J., van Hoang M., Kott J., Maciewicz R.A., and Humphries M.J. Integrin alpha5beta1 and ADAM-17 interact in vitro and co-localize in migrating HeLa cells. J. Biol. Chem. 279 (2004) 22377-22386
14. Trochon-Joseph V., Martel-Renoir D., Mir L.M., Thomaidis A., Opolon P., Connault E., Li H., Grenet C., Fauvel-Lafeve F., Soria J., Legrand C., Soria C., Perricaudet M., and Lu H. Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin. Cancer Res. 64 (2004) 2062-2069
15. Berthod F., and Damour O. In vitro reconstructed skin models for wound coverage in deep burns. Br. J. Dermatol. 136 (1997) 809-816
16. Silletti S., Kessler T., Goldberg J., Boger D.L., and Cheresh D.A. Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. Proc. Natl. Acad. Sci. USA 98 (2001) 119-124
17. Lafleur M.A., Handsley M.M., Knauper V., Murphy G., and Edwards D.R. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J. Cell Sci. 115 (2002) 3427-3438
18. Lafleur M.A., Hollenberg M.D., Atkinson S.J., Knauper V., Murphy G., and Edwards D.R. Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species. Biochem. J. 357 (2001) 107-115
19. Huang J., Bridges L.C., and White J.M. Selective modulation of integrin-mediated cell migration by distinct ADAM family members. Mol. Biol. Cell 16 (2005) 4982-4991
20. Deryugina E.I., Ratnikov B., Monosov E., Postnova T.I., DiScipio R., Smith J.W., and Strongin A.Y. MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp. Cell Res. 263 (2001) 209-223